1. Home
  2. WHF vs CLYM Comparison

WHF vs CLYM Comparison

Compare WHF & CLYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WHF
  • CLYM
  • Stock Information
  • Founded
  • WHF 2011
  • CLYM 2018
  • Country
  • WHF United States
  • CLYM United States
  • Employees
  • WHF N/A
  • CLYM N/A
  • Industry
  • WHF Finance Companies
  • CLYM
  • Sector
  • WHF Finance
  • CLYM
  • Exchange
  • WHF Nasdaq
  • CLYM NYSE
  • Market Cap
  • WHF 243.6M
  • CLYM 242.8M
  • IPO Year
  • WHF 2012
  • CLYM 2021
  • Fundamental
  • Price
  • WHF $10.49
  • CLYM $3.00
  • Analyst Decision
  • WHF Hold
  • CLYM
  • Analyst Count
  • WHF 4
  • CLYM 0
  • Target Price
  • WHF $12.25
  • CLYM N/A
  • AVG Volume (30 Days)
  • WHF 88.7K
  • CLYM 317.4K
  • Earning Date
  • WHF 11-07-2024
  • CLYM 11-12-2024
  • Dividend Yield
  • WHF 14.67%
  • CLYM N/A
  • EPS Growth
  • WHF N/A
  • CLYM N/A
  • EPS
  • WHF 0.45
  • CLYM N/A
  • Revenue
  • WHF $97,441,000.00
  • CLYM N/A
  • Revenue This Year
  • WHF N/A
  • CLYM N/A
  • Revenue Next Year
  • WHF N/A
  • CLYM N/A
  • P/E Ratio
  • WHF $23.44
  • CLYM N/A
  • Revenue Growth
  • WHF N/A
  • CLYM N/A
  • 52 Week Low
  • WHF $10.42
  • CLYM $2.35
  • 52 Week High
  • WHF $13.44
  • CLYM $11.55
  • Technical
  • Relative Strength Index (RSI)
  • WHF 26.25
  • CLYM N/A
  • Support Level
  • WHF $10.49
  • CLYM N/A
  • Resistance Level
  • WHF $11.79
  • CLYM N/A
  • Average True Range (ATR)
  • WHF 0.22
  • CLYM 0.00
  • MACD
  • WHF -0.07
  • CLYM 0.00
  • Stochastic Oscillator
  • WHF 5.11
  • CLYM 0.00

About WHF WhiteHorse Finance Inc.

WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate attractive risk-adjusted returns for investors, primarily by originating senior secured loans to privately held small-cap companies across a broad range of industries.

About CLYM CLIMB BIO INC

Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.

Share on Social Networks: